Envoy Medical, Inc. (COCH)
NASDAQ: COCH · IEX Real-Time Price · USD
3.050
+0.020 (0.66%)
At close: May 23, 2024, 3:59 PM
3.100
+0.050 (1.64%)
After-hours: May 23, 2024, 7:52 PM EDT

Envoy Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021
Revenue
0.320.240.31
Revenue Growth (YoY)
33.33%-23.55%-
Cost of Revenue
0.790.50.77
Gross Profit
-0.47-0.26-0.46
Selling, General & Admin
8.943.472.47
Research & Development
8.964.983.94
Operating Expenses
17.98.456.41
Operating Income
-18.37-8.71-6.87
Other Expense / Income
11.547.221.8
Pretax Income
-29.91-15.92-8.68
Net Income
-29.91-15.92-8.68
Preferred Dividends
002
Net Income Common
-29.91-15.92-10.68
Shares Outstanding (Basic)
1310139
Shares Outstanding (Diluted)
1310139
Shares Change
24.00%-92.73%-
EPS (Basic)
-2.38-1.57-0.08
EPS (Diluted)
-2.38-1.57-0.08
Free Cash Flow
-17.81-9.02-7.06
Free Cash Flow Per Share
-1.42-0.89-0.05
Gross Margin
-149.68%-110.13%-148.06%
Operating Margin
-5813.61%-3673.42%-2216.45%
Profit Margin
-9464.56%-6718.57%-3443.55%
Free Cash Flow Margin
-5635.13%-3807.17%-2277.74%
EBITDA
-29.78-15.85-8.6
EBITDA Margin
-9422.47%-6686.92%-2775.48%
Depreciation & Amortization
0.130.080.07
EBIT
-29.91-15.92-8.68
EBIT Margin
-9464.56%-6718.57%-2798.39%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).